NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 0.9940
-0.0080 (-0.80%)
Aug 13, 2026, 4:42 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 126.65 million as of August 13, 2026. Its market cap has decreased by -5.41% in one year.
Market Cap
126.65M
Enterprise Value
94.32M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.99
ChartMarket Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 126.65M, an increase of 283.47%. That is a compound annual growth rate of 15.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 126.65M | 55.53% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alzinova AB | 186.83M |
| Initiator Pharma | 173.19M |
| Abera Bioscience AB | 166.45M |
| Diamyd Medical AB | 160.25M |
| Xintela AB | 155.89M |
| Biovica International AB | 152.96M |
| Nanologica AB | 148.60M |
| Simris Group AB (PUBL) | 141.05M |